A new bulge or a change in contour after filler is a reason for assessment, not enough information to diagnose migration from a photograph. Migration means material has moved from its original placement. Swelling, the original placement, excess volume and inflammatory problems can create different concerns that may look similar.
The useful first step is to identify what has changed and whether there are symptoms that need prompt care. Choosing a correction before answering that question can lead to the wrong treatment.
Timing helps, but does not settle the diagnosis
Swelling soon after injection and a lump that appears months later have different contexts. Filler complications can also present long after treatment. Published migration cases include delayed swelling or a mass near a previously treated area. These reports demonstrate that migration can happen; they do not tell us how often it happens in everyone treated. Filler migration: mechanisms and three cases, 2015.
Write down when you first noticed the change, whether it fluctuates, whether it is painful and whether there is redness or warmth. Bring older photographs if you have them. Similar lighting and facial position make a comparison more useful than a single close-up taken under harsh light.
Treatment records make the assessment more useful
Ask your previous clinic for the product, dates and treated areas. Include treatments you had years ago, even if you assumed the visible effect had worn off. If records are unavailable, say so; guessing the product can give the assessment a misleading starting point.
An in-person examination may answer some questions. Where the finding remains uncertain, a clinician may consider imaging or referral. A retrospective ultrasound study describes findings in several nonvascular HA-filler complications, including migration and overcorrection. Imaging is a tool for a clinical question, not a guarantee that every concern can be explained by a scan. Ultrasound findings in HA filler complications, 2024.
Dissolving is not an automatic next step
The material and likely cause matter. Hyaluronic-acid filler and other filler materials do not have identical revision options. Removal or reduction can carry risks and may not be straightforward. US FDA: dermal filler risks.
Ask what the proposed intervention is expected to change and what may remain afterwards. Avoid trying to massage or correct an unexplained lump yourself. The person assessing you should explain whether observation, further investigation, treatment or referral is appropriate.
When the concern should not wait
Seek urgent assessment for unusual or worsening pain, white or dusky skin, or rapidly worsening symptoms after filler. Vision changes or stroke-like symptoms require emergency care immediately. These can signal serious complications rather than a routine contour concern. US FDA: dermal filler risks.
For a stable appearance concern, contact your treating clinician and arrange a review. Our dermal filler page explains the treatment’s intended role. At a SkinAlchemy assessment in London, Ontario, the first task is understanding the finding before deciding whether any further procedure belongs in the plan.
Related reading
I’ve had filler elsewhere. What should happen before I have more?
A new bulge or a change in contour after filler is a reason for assessment, not enough information to diagnose migration from a photograph. Migration means material has moved from its original placement. Swelling, the original placement, excess volume and inflammatory problems can create different concerns that may look similar.
The useful first step is to identify what has changed and whether there are symptoms that need prompt care. Choosing a correction before answering that question can lead to the wrong treatment.
Timing helps, but does not settle the diagnosis
Swelling soon after injection and a lump that appears months later have different contexts. Filler complications can also present long after treatment. Published migration cases include delayed swelling or a mass near a previously treated area. These reports demonstrate that migration can happen; they do not tell us how often it happens in everyone treated. Filler migration: mechanisms and three cases, 2015.
Write down when you first noticed the change, whether it fluctuates, whether it is painful and whether there is redness or warmth. Bring older photographs if you have them. Similar lighting and facial position make a comparison more useful than a single close-up taken under harsh light.
Treatment records make the assessment more useful
Ask your previous clinic for the product, dates and treated areas. Include treatments you had years ago, even if you assumed the visible effect had worn off. If records are unavailable, say so; guessing the product can give the assessment a misleading starting point.
An in-person examination may answer some questions. Where the finding remains uncertain, a clinician may consider imaging or referral. A retrospective ultrasound study describes findings in several nonvascular HA-filler complications, including migration and overcorrection. Imaging is a tool for a clinical question, not a guarantee that every concern can be explained by a scan. Ultrasound findings in HA filler complications, 2024.
Dissolving is not an automatic next step
The material and likely cause matter. Hyaluronic-acid filler and other filler materials do not have identical revision options. Removal or reduction can carry risks and may not be straightforward. US FDA: dermal filler risks.
Ask what the proposed intervention is expected to change and what may remain afterwards. Avoid trying to massage or correct an unexplained lump yourself. The person assessing you should explain whether observation, further investigation, treatment or referral is appropriate.
When the concern should not wait
Seek urgent assessment for unusual or worsening pain, white or dusky skin, or rapidly worsening symptoms after filler. Vision changes or stroke-like symptoms require emergency care immediately. These can signal serious complications rather than a routine contour concern. US FDA: dermal filler risks.
For a stable appearance concern, contact your treating clinician and arrange a review. Our dermal filler page explains the treatment’s intended role. At a SkinAlchemy assessment in London, Ontario, the first task is understanding the finding before deciding whether any further procedure belongs in the plan.
Related reading
I’ve had filler elsewhere. What should happen before I have more?
